463 results on '"Bulaj, Grzegorz"'
Search Results
52. The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells
53. Circular logic: nonribosomal peptide-like macrocyclization with a ribosomal peptide catalyst
54. [mu]-Conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels
55. Site-specific effects of diselenide bridges on the oxidative folding of a cystine knot peptide, [omega]-selenoconotoxin GVIA
56. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor
57. Structure of the analgesic [mu]-conotoxin KIIIA and effects on the structure and function of disulfide deletion
58. NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the [mu]-conotoxin SxIIIA
59. Structure, dynamics, and selectivity of the sodium channel blocker [mu]-conotoxin SIIIA
60. Role of hydroxypyrolines in the in vitro oxidative folding and biological activity of conotoxins
61. Structure and sodium channel activity of an excitatory [I.sub.1]-superfamily conotoxin
62. Novel conotoxins from Conus striatus and Conus kinoshitai selectivity block TTX-resistant sodium channels
63. Anticonvulsant effects of a galanin receptor 3 (galr3) antagonist SNAP 37889 in mouse models of seizures
64. NAX 810-2, A Novel Galanin-Based Therapy for Epilepsy
65. The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells
66. Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study
67. Propeptide does not act as an intramolecular chaperone but facilitates protein disulfide isomerase-assisted folding of a conotoxin precursor
68. Circular Logic: Nonribosomal Peptide-like Macrocyclization with a Ribosomal Peptide Catalyst
69. Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health
70. Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases
71. Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin μO§-GVIIJ
72. Conantokins Derived from the Asprella Clade Impart ConRl-B, an NMDA Receptor Antagonist with a Unique Selectivity Profile for NR2B Subunits
73. Clinical and Neurobiological Perspectives of Empowering Pediatric Cancer Patients Using Videogames
74. Probing the Redox States of Sodium Channel Cysteines at the Binding Site of μO§-Conotoxin GVIIJ
75. A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties
76. Neuroprotective and cardioprotective conopeptides: An emerging class of drug leads
77. Analgesic Properties of a Peripherally Acting and GalR2 Receptor–Preferring Galanin Analog in Inflammatory, Neuropathic, and Acute Pain Models
78. Combining Non-Pharmacological Treatments with Pharmacotherapies for Neurological Disorders: A Unique Interface of the Brain, Drug–Device, and Intellectual Property
79. Ribosomally synthesized and post-translationally modified peptide natural products : overview and recommendations for a universal nomenclature
80. On the Importance of Oxidative Folding in the Evolution of Conotoxins: Cysteine Codon Preservation through Gene Duplication and Adaptation
81. The intersection of video games and patient empowerment
82. Mammalian Neuronal Sodium Channel Blocker μ-Conotoxin BuIIIB Has a Structured N-Terminus That Influences Potency
83. Incorporation of Monodisperse Oligoethyleneglycol Amino Acids into Anticonvulsant Analogues of Galanin and Neuropeptide Y Provides Peripherally Acting Analgesics
84. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
85. Distinct Disulfide Isomers of μ-Conotoxins KIIIA and KIIIB Block Voltage-Gated Sodium Channels
86. Modulation of Conotoxin Structure and Function Is Achieved through a Multienzyme Complex in the Venom Glands of Cone Snails
87. Patient-Empowerment Interactive Technologies
88. Selective Purification of Recombinant Neuroactive Peptides Using the Flagellar Type III Secretion System
89. Stapling Mimics Noncovalent Interactions of γ-Carboxyglutamates in Conantokins, Peptidic Antagonists of N-Methyl-d-Aspartic Acid Receptors
90. Conantokins Derived from the Asprella Clade Impart conRl-B, an N-Methyl d-Aspartate Receptor Antagonist with a Unique Selectivity Profile for NR2B Subunits
91. Antinociceptive effects of novel GalR2‐specific analogs
92. Reagentless Oxidative Folding of Disulfide-Rich Peptides Catalyzed by an Intramolecular Diselenide
93. Generating Orally Active Galanin Analogues with Analgesic Activities
94. Dissecting a role of evolutionary-conserved but noncritical disulfide bridges in cysteine-rich peptides using ω-conotoxin GVIA and its selenocysteine analogs
95. Lactam-Stabilized Helical Analogues of the Analgesic μ-Conotoxin KIIIA
96. ChemInform Abstract: Anticonvulsant Neuropeptides as Drug Leads for Neurological Diseases
97. NaVβ Subunits Modulate the Inhibition of NaV1.8 by the Analgesic Gating Modifier μO-Conotoxin MrVIB
98. Anticonvulsant neuropeptides as drug leads for neurological diseases
99. Analgesic Neuropeptide W Suppresses Seizures in the Brain Revealed by Rational Repositioning and Peptide Engineering
100. Selenopeptide Analogs of EETI‐II Retain Potent Trypsin Inhibitory Activities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.